Mutations can be either dominant or recessive, and some fall somewhere in between. Whether a mutation behaves as dominant or recessive depends on what it does to the protein it encodes and whether one working copy of the gene can compensate. Most harmful mutations in nature are recessive, meaning you need two copies (one from each parent) to see their effects. But dominant mutations exist too, and a single copy is enough to cause a noticeable change.
Why Most Harmful Mutations Are Recessive
You carry two copies of nearly every gene, one from each parent. Most mutations reduce or eliminate a gene’s ability to produce a functional protein. These are called loss-of-function mutations, and they’re typically recessive because your remaining good copy can pick up the slack. In many metabolic pathways, reducing enzyme activity by as much as 50% has a negligible effect on the pathway’s overall output. This means a single working copy often produces enough protein to keep things running normally.
Cystic fibrosis is a textbook example. The disease results from mutations in a gene that controls chloride transport across cell membranes. Carriers who have one mutated copy and one normal copy are completely unaffected because the protein produced by that one functional gene provides sufficient chloride transport. Only when someone inherits two broken copies does the disease appear. The same pattern holds for Tay-Sachs disease and thalassemia.
This is also why recessive mutations persist in populations. Natural selection can only “see” a mutation when it affects the organism’s survival or reproduction. Since carriers of a single recessive mutation look and function normally, the mutation gets passed along silently for generations. In clinical databases like ClinVar, the majority of confirmed disease-causing variants are autosomal recessive.
What Makes a Mutation Dominant
A mutation is dominant when a single copy is enough to cause a visible effect, even with a normal copy of the gene still present. This happens through several distinct mechanisms.
Haploinsufficiency: For some genes, 50% of the normal protein level simply isn’t enough. When one copy is knocked out and the remaining copy can’t produce enough protein to maintain normal function, the result is a dominant disorder. Marfan syndrome works this way. A mutation in just one copy of the gene for fibrillin, a structural protein in connective tissue, produces defective tissue even though the other copy is intact. The body needs close to full output from both copies, so losing one matters.
Gain of function: Some mutations don’t just break a protein; they give it a new or exaggerated activity. Huntington’s disease is caused by an expanded DNA repeat that gives the huntingtin protein a toxic new behavior. The normal copy of the gene can’t counteract this because the problem isn’t insufficient protein. It’s that the mutant protein is actively doing something harmful.
Dominant negative effects: In some cases, the mutant protein directly sabotages the normal protein. The tumor suppressor p53, sometimes called the “guardian of the genome,” works as a four-unit complex. When a mutant version of p53 gets incorporated into that complex, it prevents the normal p53 proteins from binding to their target genes. The result is that one bad copy effectively disables the good copy’s ability to suppress tumor growth.
The In-Between: Incomplete Dominance and Codominance
Not every mutation fits neatly into a dominant or recessive category. In incomplete dominance, having one copy of a mutation produces an intermediate effect, a phenotype that’s a blend of the two-copy and zero-copy states. The classic example comes from snapdragon flowers: crossing a red-flowered plant with a white-flowered plant produces pink offspring. The single copy of the red allele makes some pigment, but not as much as two copies would.
Codominance is slightly different. Instead of blending, both versions of the gene are fully expressed at the same time. Sickle cell disease illustrates this well. People with two copies of the sickle cell mutation have sickle cell disease. People with one copy produce both normal and sickle-shaped hemoglobin simultaneously. Their red blood cells are a mixture of both types. At the molecular level, neither allele “wins.” Whether that person experiences symptoms depends on the proportion of affected cells and the conditions they encounter.
Human blood types also show codominance. In the MN blood group system, people who inherit one M allele and one N allele display both M and N markers on their red blood cells in equal numbers, rather than one masking the other.
Why This Matters at a Practical Level
Whether a mutation is dominant or recessive changes everything about how a genetic condition runs through a family. Recessive conditions can skip generations entirely. Two perfectly healthy parents who each carry one copy of a recessive mutation have a 25% chance of having an affected child with each pregnancy, but neither parent shows any sign of the condition. This is why genetic carrier screening exists for diseases like cystic fibrosis and Tay-Sachs.
Dominant conditions, by contrast, typically appear in every generation. If one parent carries a dominant mutation, each child has a 50% chance of inheriting it. There’s no silent carrier state because one copy is enough to produce the condition. That said, dominant conditions can vary in severity from person to person, even within the same family, because other genes and environmental factors influence how strongly the mutation’s effects are expressed.
Roughly speaking, any given mutation’s behavior comes down to one question: can one good copy of the gene do the job? If yes, the mutation is recessive. If one good copy isn’t enough, or if the mutant protein actively causes harm, the mutation is dominant. And for some genes, one copy does part of the job, landing you somewhere in between.